+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pharmacokinetics Services Market by Type (Large Molecules Pharmacokinetics Services, Small Molecules Pharmacokinetics Services), Application (Large Enterprise, Small and Medium Enterprise) - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889057
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pharmacokinetics Services Market size was estimated at USD 1.04 billion in 2023, USD 1.11 billion in 2024, and is expected to grow at a CAGR of 7.37% to reach USD 1.71 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmacokinetics Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmacokinetics Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmacokinetics Services Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Allucent, Aurigene Pharmaceutical Services Ltd., Certara, Charles River Laboratories, Inc., Creative Bioarray, Eurofins Scientific SE, Evotec SE, Frontage Laboratories, Inc., ICON PLC, Laboratory Corporation of America Holdings, LGC Limited, NUVISAN Pharma Holding GmbH, Pacific BioLabs, Parexel International (MA) Corporation, Pfizer Inc., PPD Inc. by Thermo Fisher Scientific Inc., Premier Consulting, Reaction Biology Corporation, SGS SA, Svar Life Science AB, WuXi AppTec Co., Ltd., XenoTech, and Xyzagen.

Market Segmentation & Coverage

This research report categorizes the Pharmacokinetics Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Large Molecules Pharmacokinetics Services
    • Small Molecules Pharmacokinetics Services
  • Application
    • Large Enterprise
    • Small and Medium Enterprise
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pharmacokinetics Services Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmacokinetics Services Market?
  3. What are the technology trends and regulatory frameworks in the Pharmacokinetics Services Market?
  4. What is the market share of the leading vendors in the Pharmacokinetics Services Market?
  5. Which modes and strategic moves are suitable for entering the Pharmacokinetics Services Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharmacokinetics Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Demand for personalized medicine that requires personalized pharmacokinetic assessments
5.1.1.2. Increased demand for cost-effective drug development and clinical trial designs
5.1.1.3. Government support for pharmacokinetics research and services
5.1.2. Restraints
5.1.2.1. High costs associated with the development of novel drugs that require pharmacokinetic assessment
5.1.3. Opportunities
5.1.3.1. Implementation of advanced technologies in pharmacokinetics
5.1.3.2. Growing use of predictive analytics to improve efficiency and accuracy of predictions based on PK data
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for the approval of drugs and therapies related to pharmacokinetics services
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Pharmacokinetics Services Market, by Type
6.1. Introduction
6.2. Large Molecules Pharmacokinetics Services
6.3. Small Molecules Pharmacokinetics Services
7. Pharmacokinetics Services Market, by Application
7.1. Introduction
7.2. Large Enterprise
7.3. Small and Medium Enterprise
8. Americas Pharmacokinetics Services Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pharmacokinetics Services Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Pharmacokinetics Services Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Absorption Systems LLC
12.1.2. Allucent
12.1.3. Aurigene Pharmaceutical Services Ltd.
12.1.4. Certara
12.1.5. Charles River Laboratories, Inc.
12.1.6. Creative Bioarray
12.1.7. Eurofins Scientific SE
12.1.8. Evotec SE
12.1.9. Frontage Laboratories, Inc.
12.1.10. ICON PLC
12.1.11. Laboratory Corporation of America Holdings
12.1.12. LGC Limited
12.1.13. NUVISAN Pharma Holding GmbH
12.1.14. Pacific BioLabs
12.1.15. Parexel International (MA) Corporation
12.1.16. Pfizer Inc.
12.1.17. PPD Inc. by Thermo Fisher Scientific Inc.
12.1.18. Premier Consulting
12.1.19. Reaction Biology Corporation
12.1.20. SGS SA
12.1.21. Svar Life Science AB
12.1.22. WuXi AppTec Co., Ltd.
12.1.23. XenoTech
12.1.24. Xyzagen
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. PHARMACOKINETICS SERVICES MARKET RESEARCH PROCESS
FIGURE 2. PHARMACOKINETICS SERVICES MARKET SIZE, 2022 VS 2030
FIGURE 3. PHARMACOKINETICS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMACOKINETICS SERVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PHARMACOKINETICS SERVICES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PHARMACOKINETICS SERVICES MARKET DYNAMICS
FIGURE 7. PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. PHARMACOKINETICS SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. PHARMACOKINETICS SERVICES MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. PHARMACOKINETICS SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PHARMACOKINETICS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACOKINETICS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PHARMACOKINETICS SERVICES MARKET SIZE, BY LARGE MOLECULES PHARMACOKINETICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PHARMACOKINETICS SERVICES MARKET SIZE, BY SMALL MOLECULES PHARMACOKINETICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. PHARMACOKINETICS SERVICES MARKET SIZE, BY LARGE ENTERPRISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PHARMACOKINETICS SERVICES MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. CANADA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. CANADA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. MEXICO PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. MEXICO PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES PHARMACOKINETICS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CHINA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CHINA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. INDIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. INDIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. JAPAN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. JAPAN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. THAILAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. THAILAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. DENMARK PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. DENMARK PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. EGYPT PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. EGYPT PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. FINLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. FINLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. FRANCE PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. FRANCE PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. GERMANY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. GERMANY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ITALY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ITALY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. NORWAY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NORWAY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. POLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. POLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. QATAR PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. QATAR PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SPAIN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SPAIN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TURKEY PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. TURKEY PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM PHARMACOKINETICS SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM PHARMACOKINETICS SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. PHARMACOKINETICS SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 98. PHARMACOKINETICS SERVICES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 99. PHARMACOKINETICS SERVICES MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Absorption Systems LLC
  • Allucent
  • Aurigene Pharmaceutical Services Ltd.
  • Certara
  • Charles River Laboratories, Inc.
  • Creative Bioarray
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Laboratories, Inc.
  • ICON PLC
  • Laboratory Corporation of America Holdings
  • LGC Limited
  • NUVISAN Pharma Holding GmbH
  • Pacific BioLabs
  • Parexel International (MA) Corporation
  • Pfizer Inc.
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • Premier Consulting
  • Reaction Biology Corporation
  • SGS SA
  • Svar Life Science AB
  • WuXi AppTec Co., Ltd.
  • XenoTech
  • Xyzagen

Methodology

Loading
LOADING...

Table Information